Cite
HARVARD Citation
Buttiron Webber, T. et al. (2021). Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. European journal of cancer. pp. 105-112. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Buttiron Webber, T. et al. (2021). Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. European journal of cancer. pp. 105-112. [Online].